Ive been amazed at the ability of the US military to accomplish some unbelievable tasks
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and associations with progression to end-stage renal disease and mortality
New, Beatrice M
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Y., Kong A
If you want a realistic timeline for what to expect, this breakdown of realistic expectations about peptide therapy results is worth reading before you start